RBF Capital’s Medifast MED Stock Holding History

RBF Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	+109,000	New	+$1.26M	0.05%	282
2025 Q4	–	Sell	-14,895	Closed	-$204K	–	588
2025 Q3	$204K	Hold	14,895	–	–	0.01%	522
2025 Q2	$209K	Hold	14,895	–	–	0.01%	531
2025 Q1	$201K	Buy	+14,895	New	+$224K	0.01%	516
2022 Q3	–	Sell	-2,000	Closed	-$342K	–	551
2022 Q2	$342K	Sell	2,000 -100	-5%	-$17.9K	0.02%	393
2022 Q1	$359K	Sell	2,100 -1,600	-43%	-$302K	0.02%	404
2021 Q4	$775K	Buy	+3,700	New	+$765K	0.05%	308

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RBF Capital's MED Position: Q2 2026 in Review

RBF Capital opened a new position in Medifast (MED) in Q2 2026: 109,000 shares worth $1.16M. The stake represents 0.05% of the portfolio and ranks #282 among its holdings. This is a return to the name: RBF Capital previously reported a position in MED as recently as Q3 2025.

RBF Capital first reported a position in MED in Q4 2021 and has held it in 7 quarters since. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

RBF Capital held 109,000 shares of Medifast worth $1.16M as of Q2 2026.
Medifast was a new RBF Capital position in Q2 2026.
Medifast made up 0.05% of RBF Capital's portfolio in Q2 2026, its #282 holding.
RBF Capital first reported a position in Medifast in Q4 2021 and has held it in 7 quarters since.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.